Rep. Rick Larsen discloses trade(s) in ABT, APH, MCK, SPGI
Rick Larsen (WA02) disclosed 4 transactions, traded Jul 8: 2 purchases and 2 sales.
| Traded | Ticker | Company | Action | Amount | Owner |
|---|---|---|---|---|---|
| Jul 8 | ABT | Abbott Laboratories | Sell | $1,001 - $15,000 | Self |
| Jul 8 | APH | Part of advisor-driven quarterly rebalancing Amphenol Corporation | Buy | $1,001 - $15,000 | Self |
| Jul 8 | MCK | Part of advisor-driven quarterly rebalancing McKesson Corporation | Buy | $1,001 - $15,000 | Self |
| Jul 8 | SPGI | Part of advisor-driven quarterly rebalancing S&P Global Inc. | Sell | $1,001 - $15,000 | Self |
ORIGINAL FILING ↗ALL FILINGS BY RICK LARSEN →CONGRESS TRADES DASHBOARD →
Amounts are the ranges members report. Rows are read automatically from the filing; a trade split across a page break can be missed, so the original filing is the full record.
What This Means
A U.S. House member has filed financial disclosures showing transactions in four large-cap stocks spanning healthcare, industrial components, pharmaceuticals distribution, and financial services. Congressional stock trading disclosures are public record and tracked by markets observers for potential conflicts of interest or signals of legislative intent, though individual trades by members do not typically move markets on their own.
Sources (1)
Every claim below links directly to the original reporting it was drawn from. Penblock synthesizes and cross-references these sources — it doesn't originate the reporting.
- Hon. Rick LarsenSep 29, 2026View the original filing at the House Clerk ↗
How This Could Play Out
First assessed Sep 29
Resolved
UNLIKELYA formal investigation or enforcement action finding no violation would likely have minimal direct market impact on the four stocks, as the disclosure itself already satisfies transparency requirements and routine rebalancing typically carries no systemic implications.
Status quo
LIKELYThese trades remain routine congressional disclosures with no follow-up scrutiny or media amplification, leaving the four stocks unaffected by any legislative or reputational pressure tied to the transaction.
Worsens
POSSIBLEIf media or watchdog groups flag the timing or pattern of these trades as suspicious relative to committee work or legislative activity, heightened scrutiny could create temporary reputational headwinds for the affected stocks or broader pressure on congressional trading norms, though the magnitude would depend on the severity of alleged impropriety.
SPONSORED
More on Congressional Stock Trading
- Rep. James A. Himes files a Periodic Transaction ReportOct 20
- Rep. Jonathan Jackson discloses trade(s) in DDOG, EL, GH, TYG, VSATOct 19
- Rep. Michael Rulli discloses trade(s) in GOOG, WSBCOct 19
- Attorneys for Ilhan Omar seek return of items taken during home searchOct 17
- Rep. Laurel Lee discloses trade(s) in BAC, NOKBFOct 16
- Rep. Scott H. Peters files a Periodic Transaction ReportOct 15
Get the market digest by email
One email each morning: yesterday's key story and what it means for markets. Free.